Metallo-proteinase |
MMP-1 |
Tumor progression, tissue marker for progression |
[38] |
MMP-2 |
Tumor progression, tissue marker for melanoma-specific mortality |
[39, 63] |
MMP-3 |
Tumor progression, tissue marker for progression |
[38] |
MMP-7 |
Melanocyte differentiation marker |
[59] |
MMP-8 |
Host defence, serum marker |
[50] |
MMP-9 |
Malignant transformation or tumor progression |
[51, 54] |
MMP-12 |
Host defence |
[56] |
MMP-13 |
Invasion |
[45] |
MMP-21 |
Malignant transformation |
[46] |
MT1-MMP |
Invasion |
[39] |
ADAM-9 |
Invasion |
[49] |
CD10/neutral endopeptidase |
Tissue marker for progression |
[48] |
Inhibitor |
TIMP-1 |
Tumor progression |
[57] |
TIMP-3 |
Tumor progression |
[57] |
Serine protease |
uPA |
Tumor progression, marker for malignancy |
[79, 80] |
tPA |
Proliferation |
[83, 87] |
CD26/DPP IV |
Melanocyte differentiation marker |
[90] |
DPP II |
Proliferation |
[88] |
Inhibitor |
Maspin |
Marker for benign lesions, suppressor of proliferation and invasion |
[92] |
PAI-1 |
Tumor progression, blood marker for malignancy |
[79, 96] |
Cysteine protease |
Cathepsin A |
Transformation |
[125] |
Cathepsin B |
Tumor progression |
[106] |
Cathepsin D |
Malignant transformation |
[123] |
Cathepsin L |
Tumor progression |
[107] |
Cathepsin K |
ECM degradation |
[126] |
Cathepsin E |
Host defense |
[127] |
Cathepsin H |
Host defense |
[91] |
Inhibitor |
Cystatin C |
Host defense |
[118] |